The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency’s work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading ->

Access to powerful painkillers, usually based on opioid substances, is a crucial part of progress towards tackling NCDs, according to the International Narcotics Control Board (INCB), a UN quasi-judicial body that is concerned with enforcing three global drug control conventions. Continue reading ->

Image Credits: International Narcotics Control Board and WHO Global Health Estimates, 2015. See additional online material for methods..

As the 2018 International AIDS Conference kicks off in Amsterdam (23-27 July), Gottfried Hirnschall, Director of the HIV/AIDS Department and the Global Hepatitis Programme of the World Health Organization, discussed in a wide-ranging interview with John Zarocostas for Health Policy Watch the advances, setbacks, and challenges ahead in the global fight against the HIV/AIDS epidemic. On 18 July, a new report by UNAIDS warned that new infections are rising in around 50 countries, and that AIDS-related deaths are not falling fast enough and flat resources are threatening success.

Dr Hirnschall leads the WHO’s work in development and implementation of cutting-edge normative policies and guidance, and of technical support to countries to scale up national responses to HIV and hepatitis. He also oversees the Global Hepatitis Programme, which coordinates the organisation’s response to viral hepatitis. Hirnschall holds an MD from the University of Vienna, Austria, and an MPH from the Johns Hopkins Bloomberg School of Public Health. Continue reading ->

Image Credits: WHO.

Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. Continue reading ->

Image Credits: Government of Switzerland.

Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading ->

Image Credits: Catherine Saez.